Schedule 13G ownership disclosure

Immuneering Corp

Security class unavailable · CUSIP: 45254E107

Event date: 2024-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
910,266
Percent of class
3.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-24-000835
Form type
SC 13G/A
Filer
Immuneering Corp
CIK
CIK 1790340
Filed
Apr 10, 2024
Reporting period
Mar 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub